Influenza virus vaccine liposomal intranasal - Berna Biotech
Alternative Names: NasalfluLatest Information Update: 13 Mar 2006
At a glance
- Originator Berna Biotech
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Influenza virus infections
Most Recent Events
- 06 Jun 2002 Discontinued - Preregistration for Influenza virus infections in Germany (Intranasal)
- 14 Sep 2001 Withdrawn for Influenza virus infections in Switzerland (Intranasal)
- 24 Jul 2001 The Swiss Serum and Vaccine Institute Berne is now called Berna Biotech